Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette McWilliams

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Internal Medicine Journal|December 13, 2025
Hepatic steatosis detected on low-dose computed tomography in high-risk participants of a lung cancer screening program: a retrospective observational studyAsha Bonney, Michelle Chua, Diane Pascoe, et al.
JTO Clinical and Research Reports|February 19, 2024
A Prospective Observational Study of Physical Activity Levels and Physical Fitness of People at High Risk for Lung CancerAsha Bonney, Catherine L Granger, Daniel Steinfort, et al.
Thorax|April 24, 2025
Future risk projection to engage 'near-miss' individuals in lung cancer screening eligibility: an analysis of ILST dataChellan Kumarasamy, Kim Betts, Richard Norman, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|January 19, 2026
Engaging Culturally and Linguistically Diverse Communities to Prepare for Lung Cancer Screening Implementation in Australia: A Qualitative Focus Group StudyTescha Nicholls, Sarah York, Nathan J Harrison, et al.
Respirology (Carlton, Vic.)|August 13, 2024
Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancerJessica Nash, Emily Stone, Shalini Vinod, et al.
British Journal of Cancer|November 3, 2022
Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomesSilvia Behar Harpaz, Marianne F Weber, Stephen Wade, et al.
Health and Quality of Life Outcomes|January 25, 2024
Validation of the psychosocial consequences of screening in lung cancer questionnaire in the international lung screen trial Australian cohortAsha Bonney, John Brodersen, Volkert Siersma, et al.
BMC Pulmonary Medicine|November 17, 2020
Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening populationJohn R Goffin, Gregory R Pond, Serge Puksa, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2007
Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancerSteinn Jonsson, Marileila Varella-Garcia, York E Miller, et al.
Science Translational Medicine|April 9, 2010
Airway PI3K pathway activation is an early and reversible event in lung cancer developmentAdam M Gustafson, Raffaella Soldi, Christina Anderlind, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Internal Medicine Journal|December 13, 2025
Hepatic steatosis detected on low-dose computed tomography in high-risk participants of a lung cancer screening program: a retrospective observational studyAsha Bonney, Michelle Chua, Diane Pascoe, et al.
JTO Clinical and Research Reports|February 19, 2024
A Prospective Observational Study of Physical Activity Levels and Physical Fitness of People at High Risk for Lung CancerAsha Bonney, Catherine L Granger, Daniel Steinfort, et al.
Thorax|April 24, 2025
Future risk projection to engage 'near-miss' individuals in lung cancer screening eligibility: an analysis of ILST dataChellan Kumarasamy, Kim Betts, Richard Norman, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|January 19, 2026
Engaging Culturally and Linguistically Diverse Communities to Prepare for Lung Cancer Screening Implementation in Australia: A Qualitative Focus Group StudyTescha Nicholls, Sarah York, Nathan J Harrison, et al.
Respirology (Carlton, Vic.)|August 13, 2024
Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancerJessica Nash, Emily Stone, Shalini Vinod, et al.
British Journal of Cancer|November 3, 2022
Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomesSilvia Behar Harpaz, Marianne F Weber, Stephen Wade, et al.
Health and Quality of Life Outcomes|January 25, 2024
Validation of the psychosocial consequences of screening in lung cancer questionnaire in the international lung screen trial Australian cohortAsha Bonney, John Brodersen, Volkert Siersma, et al.
BMC Pulmonary Medicine|November 17, 2020
Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening populationJohn R Goffin, Gregory R Pond, Serge Puksa, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2007
Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancerSteinn Jonsson, Marileila Varella-Garcia, York E Miller, et al.
Science Translational Medicine|April 9, 2010
Airway PI3K pathway activation is an early and reversible event in lung cancer developmentAdam M Gustafson, Raffaella Soldi, Christina Anderlind, et al.
Pageof 8